(Q34181008)

31 July 2017

Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women (English)

1 reference

31 July 2017

0 references

José Luis Pérez-Castrillón

1

1 reference

31 July 2017

Florentino Pinacho

2

1 reference

31 July 2017

Daniel De Luis

3

1 reference

31 July 2017

María Lopez-Menendez

4

1 reference

31 July 2017

Antonio Dueñas Laita

5

1 reference

31 July 2017

14 June 2010

1 reference

31 July 2017

Journal of Osteoporosis

1 reference

31 July 2017

2010

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Cathepsin K inhibitors for osteoporosis and potential off-target effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Giant osteoclast formation and long-term oral bisphosphonate therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Bone density, strength, and formation in adult cathepsin K (-/-) mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Anti-resorptive therapies for osteoporosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Osteoclast lineage and function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Cathepsin K inhibitors: a novel target for osteoporosis therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Biochemical properties and regulation of cathepsin K activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

The role of T lymphocytes in bone metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Minireview: the OPG/RANKL/RANK system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Osteonecrosis of the jaw--a potential adverse effect of bisphosphonate treatment.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.4061%2F2010%2F401581

Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4061%2F2010%2F401581

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951121

Catepsina K: aspectos biológicos y posibilidades terapéuticas

28 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.4061%2F2010%2F401581

Bisphosphonates and osteonecrosis of the jaw

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20948576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4061/2010/401581

1 reference

31 July 2017

1 reference

31 July 2017

1 reference